JPMorgan Chase & Co. Sells 13,355 Shares of U.S. Physical Therapy, Inc. (USPH)

Share on StockTwits

JPMorgan Chase & Co. cut its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 45.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,993 shares of the company’s stock after selling 13,355 shares during the period. JPMorgan Chase & Co. owned about 0.13% of U.S. Physical Therapy worth $1,300,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Stratos Wealth Partners LTD. bought a new stake in U.S. Physical Therapy during the 1st quarter worth approximately $109,000. UBS Asset Management Americas Inc. bought a new stake in U.S. Physical Therapy during the 4th quarter worth approximately $206,000. Atria Investments LLC bought a new stake in U.S. Physical Therapy during the 1st quarter worth approximately $207,000. M&T Bank Corp bought a new stake in U.S. Physical Therapy during the 1st quarter worth approximately $229,000. Finally, Envestnet Asset Management Inc. grew its position in U.S. Physical Therapy by 48.6% during the 4th quarter. Envestnet Asset Management Inc. now owns 3,704 shares of the company’s stock worth $267,000 after acquiring an additional 1,212 shares during the last quarter. 96.65% of the stock is owned by institutional investors and hedge funds.

In related news, Director Mark J. Brookner sold 1,250 shares of U.S. Physical Therapy stock in a transaction dated Wednesday, May 16th. The stock was sold at an average price of $91.83, for a total transaction of $114,787.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Christopher J. Reading sold 2,672 shares of U.S. Physical Therapy stock in a transaction dated Friday, May 11th. The stock was sold at an average price of $92.16, for a total value of $246,251.52. The disclosure for this sale can be found here. Insiders have sold 19,561 shares of company stock valued at $1,800,003 in the last quarter. 2.50% of the stock is currently owned by corporate insiders.

Several brokerages have recently weighed in on USPH. Zacks Investment Research cut U.S. Physical Therapy from a “hold” rating to a “sell” rating in a report on Saturday, July 7th. ValuEngine upgraded U.S. Physical Therapy from a “buy” rating to a “strong-buy” rating in a report on Tuesday, June 26th. Cantor Fitzgerald cut U.S. Physical Therapy from an “overweight” rating to a “neutral” rating in a report on Friday, May 4th. They noted that the move was a valuation call. Finally, Sidoti cut U.S. Physical Therapy from a “buy” rating to a “neutral” rating in a report on Wednesday, April 25th. One analyst has rated the stock with a sell rating, five have given a hold rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $82.25.

U.S. Physical Therapy stock opened at $98.85 on Monday. U.S. Physical Therapy, Inc. has a 52 week low of $56.50 and a 52 week high of $101.75. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.67 and a quick ratio of 1.67. The stock has a market cap of $1.25 billion, a P/E ratio of 47.52, a price-to-earnings-growth ratio of 3.60 and a beta of 1.04.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Thursday, May 3rd. The company reported $0.56 EPS for the quarter, hitting analysts’ consensus estimates of $0.56. U.S. Physical Therapy had a return on equity of 13.20% and a net margin of 4.90%. The business had revenue of $108.34 million during the quarter, compared to analysts’ expectations of $107.18 million. sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.44 EPS for the current year.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Further Reading: Are analyst ratings accurate?

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Symantec  Price Target Increased to $20.00 by Analysts at Deutsche Bank
Symantec Price Target Increased to $20.00 by Analysts at Deutsche Bank
Barrington Research Lowers Lions Gate Entertainment Corp. Class A  Price Target to $27.00
Barrington Research Lowers Lions Gate Entertainment Corp. Class A Price Target to $27.00
News Corp Class A  Upgraded to “Hold” at Zacks Investment Research
News Corp Class A Upgraded to “Hold” at Zacks Investment Research
Covia  Receives “Buy” Rating from Jefferies Financial Group
Covia Receives “Buy” Rating from Jefferies Financial Group
$0.50 EPS Expected for Government Properties Income Trust  This Quarter
$0.50 EPS Expected for Government Properties Income Trust This Quarter
Paragon  Price Hits $0.0702 on Top Exchanges
Paragon Price Hits $0.0702 on Top Exchanges


© 2006-2018 Ticker Report. Google+.